Prosecution Insights
Last updated: May 29, 2026
Application No. 18/526,822

AFLATOXIN REDUCTION IN NUTS VIA UV AND/OR OXIDATION

Non-Final OA §102§103
Filed
Dec 01, 2023
Priority
Dec 02, 2022 — provisional 63/429,739
Examiner
BECKER, DREW E
Art Unit
1792
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Olam Americas LLC
OA Round
1 (Non-Final)
49%
Grant Probability
Moderate
1-2
OA Rounds
8m
Est. Remaining
49%
With Interview

Examiner Intelligence

Grants 49% of resolved cases
49%
Career Allowance Rate
422 granted / 862 resolved
-16.0% vs TC avg
Minimal +0% lift
Without
With
+0.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
36 currently pending
Career history
898
Total Applications
across all art units

Statute-Specific Performance

§101
0.3%
-39.7% vs TC avg
§103
73.2%
+33.2% vs TC avg
§102
3.1%
-36.9% vs TC avg
§112
2.5%
-37.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 862 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1-3, 10 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Newman [US 2009/0311392A1]. Newman teaches a method for decontamination and detoxification of nuts (title) by applying UV light to the nuts (page 13, claim 1), applying an acid wash (page 13, claim 1), the nuts being almonds, pecans, peanuts, walnuts, and/or pistachios (paragraph 0055), and a reduction or elimination of aflatoxin (paragraph 0055). Claims 1-2, 10 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Dalmasso et al [Pat. No. 5,460,845]. Dalmasso et al teach a method for food decontamination (title) by treating nuts with hydrogen peroxide vapor (abstract), the contaminants including Aspergillus (column 4, line 43), and treatment of walnuts (column 4, line 62). Claims 1-5 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Shuman et al [US 2004,0052702A1]. Shuman et al teach method for food product surface sterilization (title) by treatment with a germicidal such as ozone and/or UV light (page 32, claim 17-18), the food being nuts (page 32, claim 25), and a reduction of Aspergillus flavus (page 16, Table 2). Claims 1-5, 10 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Shen et al [Decomposing Aflatoxins in Peanuts Using Advanced Oxidation Process by UV and H2O2]. Shen et al teach a method for Decomposing Aflatoxins in Peanuts Using Advanced Oxidation Process by UV and H2O2 (title) and the combination of known treatments (ie UV and peroxide) providing a synergistic effect on aflatoxin reduction (page 1656, Conclusions). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 6-9 are rejected under 35 U.S.C. 103 as being unpatentable over Shuman et al as applied above, and further in view of Shen et al. Shuman et al teach the abovementioned concepts and components, as well as using up to four treatments including UV light and ozone (page 32, claim 17-18). Shuman et al do not explicitly recite using peroxide (claim 6-9). Shen et al teach a method for Decomposing Aflatoxins in Peanuts Using Advanced Oxidation Process by UV and H2O2 (title) and the combination of known treatments (ie UV and peroxide) providing a synergistic effect on aflatoxin reduction (page 1656, Conclusions). It would have been obvious to one of ordinary skill in the art to incorporate the claimed peroxide treatment into the invention of Shuman et al, in view of Shen et al, since both are directed to methods of decontaminating foods, since Shuman et al already included using up to four germicidal treatments including UV light and ozone (page 32, claim 17-18) but simply did not mention peroxide specifically, since the combination of UV light and peroxide provided a synergistic effect on aflatoxin reduction (page 1656, Conclusions) as shown by Shen et al, since using further treatment modes (ie peroxide) in the method of Shuman et al would have better ensured reduction/elimination of harmful pathogens and/or toxins which might otherwise survive treatment with only UV and ozone, and since a more effective and/or efficient process for decontamination would have enabled a safer product for the consumer of Shuman et al, in view of Shen et al. Any inquiry concerning this communication or earlier communications from the examiner should be directed to DREW E BECKER whose telephone number is (571)272-1396. The examiner can normally be reached 8am-5pm Monday-Friday. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Erik Kashnikow can be reached at 571-270-3475. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /DREW E BECKER/Primary Examiner, Art Unit 1792
Read full office action

Prosecution Timeline

Dec 01, 2023
Application Filed
Jan 22, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12635705
METHOD TO ROAST COFFEE BEANS
3y 1m to grant Granted May 26, 2026
Patent 12616225
A PETFOOD COMPOSITION AND PROCESS FOR PREPARATION THEREOF
4y 9m to grant Granted May 05, 2026
Patent 12616228
FOOD PROCESS LINE FOR IN-LINE PROCESSING FOOD AND METHOD FOR PROCESSING FOOD
4y 0m to grant Granted May 05, 2026
Patent 12618030
SONIC INFUSION OF ALCOHOL
3y 9m to grant Granted May 05, 2026
Patent 12604914
DEMINERALISED LACTOSE CONCENTRATE
2y 10m to grant Granted Apr 21, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
49%
Grant Probability
49%
With Interview (+0.2%)
3y 2m (~8m remaining)
Median Time to Grant
Low
PTA Risk
Based on 862 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month